(Q41936605)

14 October 2017

title

Hydroxychloroquine, dosage parameters and retinopathy (English)

1 reference

14 October 2017

1 reference

3

G R Hughes

1 reference

14 October 2017

D J Spalton

1

1 reference

14 October 2017

G M Verdon Roe

series ordinal

2

1 reference

14 October 2017

publication date

1 December 1993

1 reference

14 October 2017

1 reference

14 October 2017

volume

2

1 reference

14 October 2017

issue

6

1 reference

14 October 2017

page(s)

355-358

1 reference

A study of the mechanisms of chloroquine retinopathy. I. Chloroquine effect on lipid peroxidation of retina

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

Screening for hydroxychloroquine retinal toxicity: is it necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

Hydroxychloroquine. Seven-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

Ocular effects and safety of antimalarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

THE PATHOLOGY OF CHLOROQUINE RETINOPATHY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

Chloroquine retinopathy. Early detection by retinal threshold test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

Incidence of chloroquine retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096120339300200604

10.1177/096120339300200604

21 January 2018

Identifiers

DOI

1 reference

14 October 2017

1 reference